DUSP1 and cancer: Collectively, these studies suggest that the dysregulation of DUSP1 expression in different stages of cancer makes targeted therapy complicated, and DUSP1 levels modulate and affect chemotherapy, radiotherapy, and immunotherapy efficacy.